These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22106072)

  • 21. The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states.
    Stein BD; Leckman-Westin E; Okeke E; Scharf DM; Sorbero M; Chen Q; Chor KH; Finnerty M; Wisdom JP
    J Child Adolesc Psychopharmacol; 2014 Sep; 24(7):374-81. PubMed ID: 25144909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in and Predictors of Long-Term Antipsychotic Polypharmacy Use Among Ohio Medicaid Patients with Schizophrenia, 2008-2014.
    Fontanella CA; Hiance-Steelesmith DL; Guirgis H; Campo JV
    Psychiatr Serv; 2018 Sep; 69(9):1015-1020. PubMed ID: 29962308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic Medications for Low-Income Preschoolers: Long Duration and Psychotropic Medication Polypharmacy.
    Lohr WD; Jawad K; Feygin Y; Le J; Creel L; Pasquenza N; Williams PG; Jones VF; Myers J; Davis DW
    Psychiatr Serv; 2022 May; 73(5):510-517. PubMed ID: 34470507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.
    Pennap D; Burcu M; Safer DJ; Zito JM
    Psychiatr Serv; 2018 Mar; 69(3):293-299. PubMed ID: 29137557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A best-worst scaling experiment to identify patient-centered claims-based outcomes for evaluation of pediatric antipsychotic monitoring programs.
    Mackie TI; Kovacs KM; Simmel C; Crystal S; Neese-Todd S; Akincigil A
    Health Serv Res; 2021 Jun; 56(3):418-431. PubMed ID: 33369739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trends in antipsychotic prescribing for approved and unapproved indications to Medicaid-enrolled youth in Philadelphia, Pennsylvania between 2014 and 2018.
    Candon M; Shen S; Fadeyibi O; Smith JL; Rothbard A
    BMC Psychiatry; 2021 Oct; 21(1):524. PubMed ID: 34686159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.
    Martin A; Van Hoof T; Stubbe D; Sherwin T; Scahill L
    Psychiatr Serv; 2003 Jan; 54(1):72-7. PubMed ID: 12509670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating clinician insight and care plans into an audit and feedback initiative for antipsychotic prescribing to Medicaid-enrolled youth in Philadelphia.
    Candon M; Shen S; Rothbard A; Reed A; Everett M; Demp N; Weingartner M; Fadeyibi O
    BMC Health Serv Res; 2024 May; 24(1):574. PubMed ID: 38702737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in Psychotropic Prescribing Patterns Among Youths in Foster Care Associated With a Peer-to-Peer Physician Consultation Program.
    Perry B; Walsh KH; Plawecki MH; Fodstad JC; Blake HS; Hunt A; Ott C; Rowlison R; McConnell WR; Kleimola K; Hulvershorn LA
    J Am Acad Child Adolesc Psychiatry; 2019 Dec; 58(12):1218-1222.e1. PubMed ID: 31374252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. State variation in psychotropic medication use by foster care children with autism spectrum disorder.
    Rubin DM; Feudtner C; Localio R; Mandell DS
    Pediatrics; 2009 Aug; 124(2):e305-12. PubMed ID: 19620187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs.
    Valuck RJ; Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R;
    Curr Med Res Opin; 2007 Oct; 23(10):2567-76. PubMed ID: 17848204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foster Care Involvement Among Youth With Intellectual and Developmental Disabilities.
    Shea L; Villodas ML; Ventimiglia J; Wilson AB; Cooper D
    JAMA Pediatr; 2024 Apr; 178(4):384-390. PubMed ID: 38345807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a claims-based antipsychotic polypharmacy measure.
    Leckman-Westin E; Kealey E; Gupta N; Chen Q; Gerhard T; Crystal S; Olfson M; Finnerty M
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):628-35. PubMed ID: 24664793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
    Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
    Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.
    Schubart JR; Camacho F; Leslie D
    Autism; 2014 Aug; 18(6):631-7. PubMed ID: 24165274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization.
    Monson ET; Shastri S; Chen D; Madden SL; Keeshin BR
    Front Psychiatry; 2023; 14():1271165. PubMed ID: 38025462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program.
    Patel NC; Crismon ML; Hoagwood K; Johnsrud MT; Rascati KL; Wilson JP
    Med Care; 2006 Jan; 44(1):87-90. PubMed ID: 16365617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing of Clozapine and Antipsychotic Polypharmacy for Schizophrenia in a Large Medicaid Program.
    Tang Y; Horvitz-Lennon M; Gellad WF; Lave JR; Chang CH; Normand SL; Donohue JM
    Psychiatr Serv; 2017 Jun; 68(6):579-586. PubMed ID: 28196460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.